Nola Masterson

nola+masterson+medium.jpg

Fund(s): FemTech Fund
Location: San Francisco Bay Area

Nola Elizabeth Masterson, MSc. is a biotechnology industry leader and forward thinker with more than 45 years of business experience in the life sciences industry and in venture capital investment. She founded Science Futures, Inc. in 1982 and as an analyst and consultant communicated the power that was to be found in the new field of biotechnology.  Masterson was  the first biotech Analyst on Wall Street working for Drexel Burnham Lambert and Merrill Lynch. Ms. Masterson worked with prominent venture funds. She has served as a Consultant at Kleiner Perkins Caufield & Byers and Oak Investments and IVP to create companies such as IDEC, Resound, and  InSite Vision.  Ms. Masterson serves as Managing Director of Science Futures Management Company, LLC and also works as an advisor, board member and investor. She has served as a Special advisor to the Board of Directors at Nativis, Inc, and is a current investor.

She is a special advisor to several private companies and is Chair Emeritus of California Life Science Institute and served as founder and General Partner of Science Futures LLC I and Science Futures LLC II. She served as a Strategy Advisor at First Warning Systems, Inc., since September 2012 now called Cyrcadia Health, Inc and is the chair of the Advisory Board. Ms. Masterson started her own venture fund in 1998. As a venture investor, she served on the Board of EpiCept Corporation and on the Board of Nanostream, Inc. She served as an Industry Advisor at TVM Capital GmbH and its Venture Partner from 2000 to 2005. She also opened the San Francisco office of TVM and became a Venture Partner.   She is the co- founder and first CEO of Sequenom, Inc. (SQNM), she has served on the Board of Directors at Omicia, Inc. now called Fabric Genomics. She served as a member of the Board and then Chairman of Repros Therapeutics Inc. (RPRX) until its sale to Allergan. She served as a Board of Director Member at EmbraceHer Innovations, Inc. and she serves as a Member of Global Advisory Board and is a Mentor at Astia, Inc. She is on the Board of Directors for Resonance-Med, a software for hearing Solutions Company in Chicago.  She recently joined the board of directors of the start-up Lynx Bio in San Diego. She is an Adjunct Professor at University of California in the School of Management, teaching the business of biotechnology. She is the co-chair of the Northern California chapter of the Women Corporate Directors. The American College of corporate Directors awarded her the Advanced Professional Director Certificate.

She is an experienced global executive having worked at Millipore for 8 years and Ames Company, a diagnostic division of Bayer. She serves on the community leadership board for the American Diabetes Association. She is a graduate of the Stanford Law School Board of Directors College course. She received a B.S. in Biology and Chemistry from Marymount College, a Medical Technology (ASCP) certification and a M.Sc. in Biological Sciences from George Washington University and completed Ph.D. course work in Molecular Biology at the University of Florida, where she taught in the Environmental Engineering Department.